Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular structural studies of human factor VIII.
McKee PA, Andersen JC, Switzer ME. McKee PA, et al. Among authors: andersen jc. Ann N Y Acad Sci. 1975 Jan 20;240:8-33. doi: 10.1111/j.1749-6632.1975.tb53319.x. Ann N Y Acad Sci. 1975. PMID: 122889 Review.
The subunit structure of normal and hemophilic factor VIII.
Shapiro GA, Andersen JC, Pizzo SV, McKee PA. Shapiro GA, et al. Among authors: andersen jc. J Clin Invest. 1973 Sep;52(9):2198-210. doi: 10.1172/JCI107405. J Clin Invest. 1973. PMID: 4199414 Free PMC article.
Training Volume Increases Or Maintenance Based On Previous Volume: The Effects On Muscular Adaptations In Trained Males.
Barsuhn A, Wadhi T, Murphy A, Zazzo S, Thompson B, Barakat C, Bradshaw J, Walters J, Andersen JC, Schoenfeld BJ, Ugrinowitsch C, De Souza EO. Barsuhn A, et al. Among authors: andersen jc. J Appl Physiol (1985). 2024 Dec 12. doi: 10.1152/japplphysiol.00476.2024. Online ahead of print. J Appl Physiol (1985). 2024. PMID: 39665246 Free article.
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer.
Schmid P, Cortes J, Dent R, McArthur H, Pusztai L, Kümmel S, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Im SA, Untch M, Fasching PA, Mouret-Reynier MA, Foukakis T, Ferreira M, Cardoso F, Zhou X, Karantza V, Tryfonidis K, Aktan G, O'Shaughnessy J; KEYNOTE-522 Investigators. Schmid P, et al. N Engl J Med. 2024 Nov 28;391(21):1981-1991. doi: 10.1056/NEJMoa2409932. Epub 2024 Sep 15. N Engl J Med. 2024. PMID: 39282906 Clinical Trial.
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.
Martín M, Lim E, Chavez-MacGregor M, Bardia A, Wu J, Zhang Q, Nowecki Z, Cruz FM, Safin R, Kim SB, Schem C, Montero AJ, Khan S, Bandyopadhyay R, Moore HM, Shivhare M, Patre M, Martinalbo J, Roncoroni L, Pérez-Moreno PD, Sohn J; acelERA Breast Cancer Study Investigators. Martín M, et al. J Clin Oncol. 2024 Jun 20;42(18):2149-2160. doi: 10.1200/JCO.23.01500. Epub 2024 Mar 27. J Clin Oncol. 2024. PMID: 38537155 Free PMC article. Clinical Trial.
97 results